Tech Company Financing Transactions
EndoStim Funding Round
Sante Ventures, private investors and Prolog Ventures invested in a $6 million Series B funding round for EndoStim. This venture round was announced on 7/19/2010.
Transaction Overview
Company Name
Announced On
7/19/2010
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Sante Ventures (Lead Investor) (Douglas French)
Proceeds Purpose
The financing will be used to continue clinical trials and pursue CE Mark and FDA approval.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4101 McEwen 336
Dallas, TX 75244
USA
Dallas, TX 75244
USA
Phone
Website
Email Address
Overview
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Goode
Chief Financial Officer
Kim Pinson
Chief Medical Officer
Virender Sharma
Browse more venture capital transactions:
Prev: 7/19/2010: Luminate venture capital transaction
Next: 7/19/2010: Eleme Medical venture capital transaction
Share this article
About Database of VC Transactions
We document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs